Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Non-Current Debt (2025)

Nuvation Bio (NUVB) has disclosed Non-Current Debt for 1 consecutive years, with $47.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Debt changed N/A to $47.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $47.2 million, a N/A change, with the full-year FY2025 number at $47.2 million, changed N/A from a year prior.
  • Non-Current Debt was $47.2 million for Q4 2025 at Nuvation Bio, roughly flat from $47.1 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $47.2 million in Q4 2025 to a low of $47.0 million in Q2 2025.